1. Shi, Haoming, Luo, Jun, Ye, Liu, Wu, Qingchen, Shao, Yue. 2023. SH2D4A inhibits esophageal squamous cell carcinoma progression through FAK/PI3K/AKT signaling pathway. In Cellular signalling, 114, 110997. doi:10.1016/j.cellsig.2023.110997. https://pubmed.ncbi.nlm.nih.gov/38043670/
2. Matsumoto, Takuro, Okayama, Hirokazu, Nakajima, Shotaro, Mimura, Kosaku, Kono, Koji. 2021. SH2D4A downregulation due to loss of chromosome 8p is associated with poor prognosis and low T cell infiltration in colorectal cancer. In British journal of cancer, 126, 917-926. doi:10.1038/s41416-021-01660-y. https://pubmed.ncbi.nlm.nih.gov/34893760/
3. Yang, Tian, Li, Chujun, Xu, Duo, Zhang, Zhengkui, Yu, Rutong. 2024. Bioinformatics analysis of SH2D4A in glioblastoma multiforme to evaluate immune features and predict prognosis. In Translational cancer research, 13, 4242-4256. doi:10.21037/tcr-23-2000. https://pubmed.ncbi.nlm.nih.gov/39262462/
4. Ploeger, Carolin, Waldburger, Nina, Fraas, Angelika, Schirmacher, Peter, Roessler, Stephanie. 2016. Chromosome 8p tumor suppressor genes SH2D4A and SORBS3 cooperate to inhibit interleukin-6 signaling in hepatocellular carcinoma. In Hepatology (Baltimore, Md.), 64, 828-42. doi:10.1002/hep.28684. https://pubmed.ncbi.nlm.nih.gov/27311882/
5. Li, Ziyao, Xin, Shiyong, Huang, Liqun, Wang, Wenwen, Ye, Lin. 2024. BEX4 inhibits the progression of clear cell renal cell carcinoma by stabilizing SH2D4A, which is achieved by blocking SIRT2 activity. In Oncogene, 44, 665-678. doi:10.1038/s41388-024-03235-6. https://pubmed.ncbi.nlm.nih.gov/39639172/
6. Wu, Yangyang, Mao, Meng, Wang, Lin-Jian. 2023. Integrated clustering signature of genomic heterogeneity, stemness and tumor microenvironment predicts glioma prognosis and immunotherapy response. In Aging, 15, 9086-9104. doi:10.18632/aging.205018. https://pubmed.ncbi.nlm.nih.gov/37698534/
7. Roessler, Stephanie, Long, Ezhou Lori, Budhu, Anuradha, Meltzer, Paul S, Wang, Xin Wei. 2011. Integrative genomic identification of genes on 8p associated with hepatocellular carcinoma progression and patient survival. In Gastroenterology, 142, 957-966.e12. doi:10.1053/j.gastro.2011.12.039. https://pubmed.ncbi.nlm.nih.gov/22202459/
智鼠故事 
